Gendicine works by combining the p53 gene, which is a tumor suppressant, with a utility virus. When the Gendicine virus is then injected into the cancerous tumor, the virus inserts the p53 gene into the cancer cells. Once the p53 gene is in the cancer cells, it causes them to self destruct. Clinical trials have shown a 64% success rate in this therapy combined with radiation therapy…. (more…)